Unsupervised hierarchical clustering identifies a metabolically challenged subgroup of hypertensive individuals

Felix C Vaura1, Veikko V Salomaa2, Ilkka M Kantola3

  • 1Department of Medicine, University of Turku, Turku, Finland.

Insights

This study identified two distinct hypertension phenotypes using cluster analysis. One group, the Metabolically Challenged, showed significantly higher cardiovascular disease risk, suggesting a need for personalized hypertension management.

Area of Science:

  • Cardiology
  • Metabolic Syndrome
  • Hypertension Research

Background:

  • Current hypertension classification lacks granularity regarding patient heterogeneity and cardiovascular outcomes.
  • Identifying distinct hypertension phenotypes is crucial for understanding differential cardiovascular risk.

Purpose of the Study:

  • To identify distinct hypertension phenotypes using data-driven cluster analysis.
  • To assess the cardiovascular disease (CVD) risk profiles associated with these identified phenotypes.

Main Methods:

  • Cluster analysis was performed on 3726 individuals with grade 2 hypertension from FINRISK cohorts.
  • Eight factors including blood pressure, cholesterol, glucose, BMI, CRP, eGFR, and alcohol intake were used for clustering.
  • Cox regression models assessed CVD outcomes relative to identified clusters and a reference group.

Main Results:

  • Two comparable hypertension clusters were identified in both men and women.
  • The Metabolically Challenged (MC) cluster exhibited elevated blood glucose and BMI.
  • The MC cluster demonstrated a 1.6-fold increased CVD risk compared to non-MC individuals and a 2.5-fold risk compared to the reference group.

Conclusions:

  • Unsupervised hierarchical clustering revealed two distinct hypertension subgroups with varying CVD risks.
  • This phenotypic substratification can inform studies on differential antihypertensive therapy effects in hypertension subgroups.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
149
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
192
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
337